Position in NVO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$24,209
+$6,092 QoQ
Shares Held
505
+2.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,172
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Godfrey Financial Associates, Inc. holds $1,800,316 across 15 Drug Manufacturers - General names. NVO ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,560 | $1,158,103 | |
| 2 | LLY |
ELI LILLY & Co
|
169 | $202,703 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,140 | $146,490 | |
| 4 | ABBV |
AbbVie Inc.
|
436 | $109,715 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
988 | $56,928 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
293 | $37,017 | |
| 7 | PFE |
Pfizer Inc
|
1,041 | $25,067 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
505 | $24,209 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,209 | 505 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $18,117 | 493 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $25,083 | 493 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||